Bristol-Myers Squibb Co. BMY
$65.31
+0.69%
at last close
Market Cap$133.41 billion
P/E Ratio14.39
Div Yield3.86%
Volume14.58M
52-Week Range
$42.52$65.66
Key Stats
- Today's Range
- $63.53 – $65.66
- 50-Day Range
- $53.44 – $65.66
- 52-Week Range
- $42.52 – $65.66
- Volume
- 14.58 million shs
- Average Volume
- 12.82 million shs
- Market Cap
- $133.41 billion
- P/E Ratio
- 14.39
- Dividend Yield
- 3.86%
Valuation
- P/E Ratio
- 14.39
- Price / Book
- 5.98
- Price / Sales
- 2.71
Dividend
- Dividend Yield
- 3.86%
- Annual Dividend
- $2.52
- Payout Ratio
- 55.51%
- Ex-Dividend Date
- 2026-07-02
Short Interest
- Short Interest
- 0.39%
- Days to Cover
- 1.64
Financials (TTM)
- Revenue
- $49.19 billion
- Net Income
- $9.27 billion
- Net Margin
- 18.85%
- Return on Equity
- 41.55%
- Debt-to-Equity
- 1.92
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.